| Sabra D Peetz, PA-C | |
|
1000 Pole Creek Xing, Sidney, NE 69162-2901 | |
| (308) 254-5825 | |
| Not Available |
| Full Name | Sabra D Peetz |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 5 Years |
| Location | 1000 Pole Creek Xing, Sidney, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003447194 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sidney Regional Medical Center | Sidney, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cheyenne County Hospital Association Inc | 1658345657 | 28 |
News Archive
A critical biomarker of kidney disease may help predict clear cell kidney cancer - the most common form of kidney cancer - years before clinical diagnosis. Kidney-injury-molecule-1 can be detected in the urine and blood and is generally present at low levels in healthy individuals.
A project by Kansas State University interior architecture & product design students is giving individuals with prosthetic limbs a chance to add some personality to their prosthetic and show the students that their discipline goes beyond creating products or designing spaces.
With the goal of developing an accurate, powerful and fast method to automate the ana-lysis of bone strength, scientists of the ETH Zurich Departments of Mechanical and Pro-cess Engineering and Computer Science teamed up with supercomputing experts at IBM's Zurich Research Laboratory. The breakthrough method developed by the team combines density measurements with a large-scale mechanical analysis of the inner-bone microstructure.
Men treated with radiotherapy as well as hormone therapy for advanced prostate cancer were 43 per cent less likely to die from the disease, according to trial results presented at the NCRI Cancer Conference in Liverpool today (Monday).
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sabra D Peetz, PA-C 11915 Us Highway 30, Sidney, NE 69162-3015 Ph: (303) 552-4422 | Sabra D Peetz, PA-C 1000 Pole Creek Xing, Sidney, NE 69162-2901 Ph: (308) 254-5825 |
News Archive
A critical biomarker of kidney disease may help predict clear cell kidney cancer - the most common form of kidney cancer - years before clinical diagnosis. Kidney-injury-molecule-1 can be detected in the urine and blood and is generally present at low levels in healthy individuals.
A project by Kansas State University interior architecture & product design students is giving individuals with prosthetic limbs a chance to add some personality to their prosthetic and show the students that their discipline goes beyond creating products or designing spaces.
With the goal of developing an accurate, powerful and fast method to automate the ana-lysis of bone strength, scientists of the ETH Zurich Departments of Mechanical and Pro-cess Engineering and Computer Science teamed up with supercomputing experts at IBM's Zurich Research Laboratory. The breakthrough method developed by the team combines density measurements with a large-scale mechanical analysis of the inner-bone microstructure.
Men treated with radiotherapy as well as hormone therapy for advanced prostate cancer were 43 per cent less likely to die from the disease, according to trial results presented at the NCRI Cancer Conference in Liverpool today (Monday).
VIVUS, Inc. today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an investigational drug, for the treatment of obstructive sleep apnea (OSA). VIVUS recently completed phase 3 development of Qnexa for the treatment of obesity and submitted a New Drug Application (NDA) to the FDA for that indication.
› Verified 9 days ago
Francelia Jo Barnes, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1000 Pole Creek Crossing, Sidney, NE 69162 Phone: 308-249-0521 | |
Jacob Dean Horstman, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1000 Pole Creek Xing, Sidney, NE 69162 Phone: 308-254-5825 | |
Nicole Linton, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1000 Pole Creek Xing, Sidney, NE 69162 Phone: 308-254-1091 Fax: 308-254-4003 | |
Leah Barjenbruch, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1000 Pole Creek Xing, Sidney, NE 69162 Phone: 308-254-5825 | |
Angela T Robb, P.A.C. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1625 Dorwart Dr, Sidney, NE 69162 Phone: 308-254-5544 Fax: 308-254-2672 | |
Kyle Alan Brown, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 830 Pine St, Sidney, NE 69162 Phone: 308-254-9192 |